You’ve done the SKU margin audit. You know your contribution margin per product, per channel. You’ve ranked the portfolio from highest to lowest, and you can see the pattern: a small cluster of SKUs carrying the business, a middling group that breaks even, and a tail of products that are silently destroying margin every time a unit ships.
Now comes the harder part — deciding what to do about it.
The diagnosis is analytical. The prescription is political. Cutting a product means telling the salesperson who built their relationships around it that it’s gone. Repositioning means admitting the original market strategy was wrong. Scaling a winner means choosing where to concentrate resources — and where not to. These decisions require a framework, because without one, every discussion collapses into competing opinions and nothing changes.
This article gives you that framework. It’s built on the classic BCG matrix — stars, cash cows, question marks, dogs — but applied to the specific constraints of hardware and physical product businesses in Singapore: minimum order quantities, tooling sunk costs, distributor contracts, regulatory certifications, and the unmistakable challenge of sunsetting a product the founder built with their own hands.
The Four-Zone Portfolio Map
Before making any decision, place every SKU into one of four zones. You need two inputs for each product: contribution margin % (from the SKU margin audit) and market position strength — a simple assessment of whether you are a market leader, a credible alternative, or a minor player in this product category.
| Strong market position | Weak market position | |
|---|---|---|
| High CM% (30%+) | ⭐ Star — Scale | 🔁 Question Mark — Reposition or invest |
| Low CM% (below 15%) | 🐄 Cash Cow — Protect and extract | 🐕 Dog — Cut or fix fast |
Most hardware portfolios, honestly mapped, look like this: 2–4 Stars generating most of the value, 3–5 Cash Cows producing reliable volume at shrinking margin, 4–8 Question Marks that nobody has made a clear decision on, and a tail of 5–10 Dogs that sales insists are “strategic” and finance has quietly written off.
The goal of the exercise is to make an explicit, time-bound decision for every product in every zone — not just the Dogs.
Zone 1: Stars — Scale with Discipline
Stars are your high-margin, market-leading products. They’re the reason the business exists. The decision here isn’t whether to invest — it’s how to scale without destroying the economics that made them valuable in the first place.
The signals that put a product here: Contribution margin consistently above 30%. Strong win rate against competitors. Short sales cycle or high repeat purchase rate. Customer references that open doors to new accounts. Inbound enquiries rather than outbound-only sales.
The decision options:
- Expand distribution: Add channels or geographies where the product’s margin profile holds. Before adding a new distributor, model the contribution margin at the distributor’s required price — if it drops below 20%, the expansion destroys value even if it grows revenue.
- Extend the product line: Add configurations, accessories, or service tiers that capture more revenue from existing customers at high margin. A SGD $2,000 device with a SGD $300/year monitoring subscription attached transforms a one-time transaction into a recurring revenue stream.
- Increase marketing investment: Stars justify higher CAC because the LTV supports it. Shift budget from broad awareness to targeted demand generation in proven segments.
The mistake to avoid: Discounting the Star to win volume. Once you establish a lower price point with a distributor or a large account, it sets a precedent that’s nearly impossible to reverse. Stars earn their margin — protect it.
Questions to answer before acting: What’s driving the Star’s margin advantage — product differentiation, cost efficiency, or channel exclusivity? Is that advantage defensible over 12–24 months? What’s the risk of a competitor closing the gap?
Zone 2: Cash Cows — Protect and Extract, Don’t Invest
Cash Cows are products with strong market position but shrinking contribution margin. They were often Stars in an earlier era — the flagship product at launch, the product that built the company’s reputation. Now, increased competition has compressed pricing, COGS has risen, and the margin that once made the product exciting is gradually eroding.
The instinct is to invest in them — to run a marketing campaign, redesign the packaging, add features. Resist it. Cash Cows are not broken. They are mature. The job is to extract maximum cash from them while they last, not to restore their youth.
The signals that put a product here: Reliable volume and revenue, but contribution margin declining quarter-on-quarter. High customer retention but very low new customer acquisition. Competitors have matched features and are pricing aggressively. Sales team spends time defending price rather than selling value.
The decision options:
- Reduce cost, not price: Renegotiate COGS with your manufacturer — Cash Cows typically have sufficient volume to justify this. Streamline the SKU (eliminate low-volume configurations). Reduce packaging complexity. Every SGD $5 saved in COGS on a product selling 3,000 units/year is SGD $15,000 back in margin. For the full framework on modelling this, see the Unit Economics Playbook.
- Simplify the channel mix: Move Cash Cows toward your most cost-efficient channels. If the product is profitable through direct B2B but marginal through Shopee, stop promoting it on Shopee and let it run through the profitable channel only.
- Attach a service or consumable: Cash Cows with a large installed base can generate recurring revenue through maintenance contracts, consumables, or upgrade programmes. This extends the product’s economic life without requiring a full development cycle.
The mistake to avoid: Cutting support for Cash Cows prematurely. They’re funding your Stars and financing your next product generation. Let them run, keep extracting, and resist the temptation to redirect resources to them.
Questions to answer before acting: What is the remaining economic life of this product before margin drops below the floor? What would a 10% COGS reduction require, and is it achievable? Is there a service or recurring revenue model that extends value for existing customers?
Zone 3: Question Marks — Force the Decision
Question Marks are the most dangerous zone — not because the products are bad, but because they create ambiguity that consumes management attention without producing results. These are products with high contribution margin potential but weak current market position. They could become Stars with the right investment and execution. Or they could become Dogs if the market doesn’t respond.
The defining characteristic of Question Mark management is indefinite deferral. “Let’s give it another quarter.” “We just need to get in front of the right buyer.” “Once we land the reference customer, it’ll take off.” Meanwhile, engineering resources, sales time, and marketing budget keep flowing into a product that hasn’t validated its commercial model.
The signals that put a product here: Strong product-market fit signals from a small number of customers but unable to scale beyond them. High contribution margin per unit but low volume. Long sales cycles with low close rates. Technically differentiated but commercially unproven.
The decision options — and this time, you must pick one:
- Invest and accelerate: Assign dedicated sales and marketing resource. Set a 6-month target: X new accounts, Y revenue, Z contribution. If the target is hit, the product graduates to Star territory. If not, it exits.
- Reposition to a different segment: The product may have found the wrong ICP. A building management IoT device that struggled with property developers may find product-market fit with logistics warehouses. Repositioning is not failure — it’s iteration.
- Partner rather than go direct: If the sales motion is too complex or expensive for your current team, find a channel partner — system integrator, value-added reseller, or industry association — who already owns the customer relationships you need.
The mistake to avoid: Funding Question Marks indefinitely without a checkpoint. If you cannot define the conditions under which this product becomes a Star — in concrete, time-bound terms — you don’t have a Question Mark, you have a Dog in disguise.
Questions to answer before acting: What would need to be true for this product to reach 30% CM at meaningful volume within 12 months? Do we have the sales capability to execute the investment option, or do we need a partner? What is the explicit exit trigger — the point at which we stop and cut?
Zone 4: Dogs — Cut, Fix, or Contain
Dogs are low-margin, weak-position products. They generate activity without generating value. The challenge isn’t identifying them — the SKU margin audit does that. The challenge is dealing with the organisational resistance to cutting them.
In Singapore hardware SMEs, Dog products survive for predictable reasons: a salesperson’s largest account buys it, so it feels strategic. The founder designed it, so cutting it feels personal. It was the original product, so there’s historical attachment. It keeps a warehouse slot full, so it feels efficient. None of these are margin arguments.
The signals that put a product here: Contribution margin below 10% or negative. Weak brand recognition relative to category leaders. High support burden relative to revenue. Sales cycle length disproportionate to deal size. Repeat purchase rate near zero.
The decision options:
- Cut: End-of-life the product. Give existing customers 60–90 days’ notice. Sell down existing inventory at a clearing price — even at cost recovery, this is better than write-down. Free up the working capital, the warehouse space, and the engineering support burden. Redirect the salesperson’s time toward Stars. This is the right decision for most Dogs.
- Fix the economics, fast: If the product has a loyal customer base but broken unit economics, you have one shot to fix it before cutting. Price increase of 15–25% with a clear value justification, COGS negotiation, or channel shift from distributor to direct. Set a 90-day window. If CM% doesn’t reach 20% within 90 days, cut.
- Contain: For Dogs that genuinely cannot be cut — regulatory requirements, anchor customer dependencies, contractual obligations — contain them. No new investment. No active sales or marketing. Fulfil existing obligations and let the product naturally wind down. This is not a growth strategy; it’s a managed exit over time.
The exception test: Before cutting, ask two questions honestly. First: does this product generate a customer relationship that buys high-margin products? If a Dog sells for SGD $500 per year but the account that buys it also buys SGD $80,000 of Stars annually, the Dog may be worth containing. Second: is there a genuine regulatory or certification reason this product must remain in the portfolio? If neither question produces a clear “yes,” the product should be cut.
The Leadership Alignment Problem
The framework above is logical. The execution is human. In every hardware SME portfolio review, the same dynamics appear — and if you don’t name them and manage them explicitly, they will derail the process.
The founder’s product
Every hardware business has at least one product the founder built themselves — the first product, the original proof of concept, the thing that made the business real. When the data says this product is a Dog, the conversation becomes existential rather than analytical.
The only way through this is to separate the decision from the person. The framework is not saying the product was a mistake — it may have been essential to build the company to where it is. It’s saying the product’s future economics don’t justify continued investment. These are different things. Name that distinction clearly and early.
The salesperson’s sacred account
Sales will always produce an account that would be endangered by cutting the product. “If we remove Product X, we lose Company Y.” The right response is to investigate, not to capitulate. What does Company Y actually buy? How much margin do they generate across the full portfolio? Is their relationship with the company or with the salesperson? Would they genuinely walk if Product X was discontinued, or would they adapt?
More often than not, the “sacred account” argument is hypothetical. The account has never actually been asked whether they would leave. And even if they would — a customer who only buys a Dog is not a customer worth retaining at that cost.
The sunk cost fallacy
“We spent SGD $200,000 on the tooling for this product. We can’t just write that off.” Yes, you can — and you should. The tooling cost is gone regardless of what you decide next. The question is not whether you can recover that SGD $200,000 by keeping the product running. The question is whether continuing to sell this product generates positive contribution margin going forward. If it doesn’t, every additional month of sales compounds the loss, it doesn’t recover the sunk cost.
How to run the alignment session
Portfolio decisions should not be made in the boardroom on the day of the review. They should be made in a structured session with the right people — founder/GM, head of sales, head of finance, and head of operations — who have all reviewed the same data in advance.
The agenda for a two-hour portfolio alignment session:
- 15 minutes: Agree on the criteria. What is the CM% floor for continued investment? What is the minimum volume threshold? What strategic exceptions are legitimate? Get these agreed before looking at any individual product.
- 30 minutes: Review Stars and Cash Cows. These are the easy decisions. Confirm investment plans for Stars. Confirm cost-reduction plans for Cash Cows. Move quickly.
- 45 minutes: Review Question Marks. For each, agree on either an investment plan with explicit success criteria and a cut trigger, or an immediate reposition/cut decision.
- 30 minutes: Review Dogs. Apply the exception test to each. For those that fail the test, agree on the cut date and the inventory clearance plan. For those that pass the exception test, agree on a containment plan and a natural end-of-life date.
Every decision made in the session should have: a named owner, a deadline, and a success metric. Without these three, the session produces consensus but not change.
Running the Framework Quarterly
Portfolio decisions are not a one-time event. The market moves. COGS changes. Competitors emerge. A Question Mark that failed this quarter may deserve a different decision next quarter if a new channel partner has been signed or a new segment identified.
Build a simple quarterly rhythm: update the contribution margin model with the latest cost and volume data, re-map every SKU to the four zones, review decisions made last quarter (were commitments followed through?), and make new decisions for any product whose zone has changed.
The businesses that consistently improve portfolio margin are not smarter than their competitors. They are more disciplined about making decisions and following through on them. A portfolio review that produces a list of actions that nobody executes is worse than no review at all — it creates the illusion of management without the substance.